MedTrace Logo

Genzyme Osteopenia/Osteoporosis Study

NCT02785744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2021-03-23

No results posted yet for this study

Summary

Gaucher disease is a most common genetic metabolic disease characterized by low platelet number, liver and spleen enlargement and various forms of bone diseases including low bone mineral density leading to brittle bones. Various treatment options are now available for this disease.

The purpose of this research study is to determine the prevalence of Gaucher disease in patients with low bone mineral density as observed by DEXA scan, which is a form of X-Ray of the bone.

Conditions

  • Gaucher Disease

Interventions

OTHER

Gaucher disease DNA mutation analysis

Sponsors & Collaborators

Principal Investigators

  • Heather Lau, MD · New York University Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2019-09-01
Completion
2019-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02785744 on ClinicalTrials.gov